Lantern Pharma (LTRN) Shares Outstanding (2019 - 2026)

Lantern Pharma (LTRN) has reported Shares Outstanding (Entity) for 8 consecutive years, with $12.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 18.31% year-over-year to $12.8 million; the trailing twelve-month figure through Jun 2026 stood at $12.8 million (up 18.31% YoY), and the FY2025 full-year result was $11.3 million, up 4.36% from the prior year.
• Shares Outstanding (Entity) improved to $12.8 million in Q2 2026 per LTRN's latest filing, from $11.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $12.8 million in Q2 2026 and bottomed at $10.7 million in Q4 2023.
• Historically, Shares Outstanding (Entity) has averaged $11.0 million across 5 years, with a median of $10.8 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) retreated 3.16% in 2022, then increased 18.31% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $10.9 million in 2022, then slipped by 1.25% to $10.7 million in 2023, then advanced by 0.59% to $10.8 million in 2024, then rose by 4.36% to $11.3 million in 2025, then gained by 13.37% to $12.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $12.8 million, $11.3 million, and $11.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.